Literature DB >> 2040056

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

C Frostell1, M D Fratacci, J C Wain, R Jones, W M Zapol.   

Abstract

Background. The gas nitric oxide (NO) is an important endothelium-derived relaxing factor, inactivated by rapid combination with heme in hemoglobin. Methods and Results. Awake spontaneously breathing lambs inhaled 5-80 ppm NO with an acutely constricted pulmonary circulation due to either infusion of the stable thromboxane endoperoxide analogue U46619 or breathing a hypoxic gas mixture. Within 3 minutes after adding 40 ppm NO or more to inspired gas, pulmonary hypertension was reversed. Systemic vasodilation did not occur. Pulmonary hypertension resumed within 3-6 minutes of ceasing NO inhalation. During U46619 infusion pulmonary vasodilation was maintained up to 1 hour without tolerance. In the normal lamb, NO inhalation produced no hemodynamic changes. Breathing 80 ppm NO for 3 hours did not increase either methemoglobin or extravascular lung water levels nor modify lung histology compared with control lambs. Conclusions. Low dose inhaled NO (5-80 ppm) is a selective pulmonary vasodilator reversing both hypoxia- and thromboxane-induced pulmonary hypertension in the awake lamb [corrected].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040056     DOI: 10.1161/01.cir.83.6.2038

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  159 in total

Review 1.  Exhaled nitric oxide during exercise.

Authors:  A W Sheel; J Road; D C McKenzie
Journal:  Sports Med       Date:  1999-08       Impact factor: 11.136

2.  Cerebral blood flow during treatment for pulmonary hypertension.

Authors:  S Kusuda; N Shishida; N Miyagi; M Hirabayashi; T J Kim
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

Review 3.  Inhaled nitric oxide and pulmonary vasoreactivity.

Authors:  M Aranda; R G Pearl
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

4.  Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

Authors:  C A Head; C Brugnara; R Martinez-Ruiz; R M Kacmarek; K R Bridges; D Kuter; K D Bloch; W M Zapol
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

5.  Endothelium derived relaxing factor/nitric oxide.

Authors:  G Blaise
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 6.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 7.  The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

Authors:  M Messent; M J Griffiths
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

8.  [Inhaled nitric oxide for the treatment of ARDS].

Authors:  H Lohbrunner; M Deja; T Busch; C D Spies; R Rossaint; U Kaisers
Journal:  Anaesthesist       Date:  2004-08       Impact factor: 1.041

9.  Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; D Pappert; K Lewandowski; R Rossaint; K J Falke
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  Inhaled nitric oxide in combination with volume resuscitation refines a porcine model of endotoxic shock.

Authors:  N A Herity; J D Allen; B Silke; A A Adgey
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.